DR. WILLIAM C MOBLEY, MD
Neurology at Welch Rd, Palo Alto, CA
License number
California G36551
Category
Neurology
Type
Neurology
Address
Address
1201 Welch Rd, Palo Alto, CA 94305
Phone
(650) 498-5858
Professional information
Dr. William C Mobley, La Jolla CA - MD (Doctor of Medicine)
Specialties:
Pediatrics, Pediatric Neurology
Address:
UCSD School-Medicine Neuroscien
9500 Gilman Dr STE 100, La Jolla 92093
(858) 534-9434 (Phone)
9500 Gilman Dr STE 100, La Jolla 92093
(858) 534-9434 (Phone)
Certifications:
Neurology with Special Qualification in Child Neurology, 1987, Pediatrics, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UCSD School-Medicine Neuroscien
9500 Gilman Dr STE 100, La Jolla 92093
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
9500 Gilman Dr STE 100, La Jolla 92093
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University
Graduated: 1976
Johns Hopkins Hospital
Stanford University
Graduated: 1976
Johns Hopkins Hospital
William Charles Mobley, Stanford CA
Specialties:
Pediatrics, Neurology, Neurology with Special Qualifications in Child Neurology
Work:
Stanford University
1201 Welch Rd, Stanford, CA 94305
1201 Welch Rd, Stanford, CA 94305
Education:
Stanford University (1976)
William C Mobley, Stanford CA
Specialties:
Neurologist
Address:
1201 Welch Rd, Stanford, CA 94305
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Psychiatry and Neurology Certification in Neurology with Special Qualification in Child Neurology (Psychiatry and Neurology)
Use Of Gpr30 Receptor Ligands To Mediate Neurotrophic Action
US Patent:
6444420, Sep 3, 2002
Filed:
Apr 26, 2001
Appl. No.:
09/844402
Inventors:
William C. Mobley - Palo Alto CA
Ronald J. Weigel - Woodside CA
Chengbiao Wu - San Jose CA
Har Hiu Dawn Lam - Stanford CA
Ronald J. Weigel - Woodside CA
Chengbiao Wu - San Jose CA
Har Hiu Dawn Lam - Stanford CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12Q 100
US Classification:
435 4, 435 691
Abstract:
Neurological dysfunction is prevented or treated by the administration of ligands that activate the GPR30 receptor. Ligands include estrogens and structurally related molecules. Preferably the GPR30 ligand is an orally available drug that can cross into the brain from blood. Screening methods are provided for ligands that do not activate other estrogen receptors, and therefore do not have the classical estrogenic effects attributable to these receptors.
Cerebrospinal Fluid Purification System
US Patent:
2014006, Mar 6, 2014
Filed:
Mar 13, 2013
Appl. No.:
13/801215
Inventors:
Shivanand Lad - Palo Alto CA, US
William C. Mobley - Stanford CA, US
Karoly Nikolich - Emerald Hill CA, US
Thomas Saul - El Granada CA, US
William C. Mobley - Stanford CA, US
Karoly Nikolich - Emerald Hill CA, US
Thomas Saul - El Granada CA, US
Assignee:
Neurofluidics, Inc. - San Mateo CA
International Classification:
A61M 27/00
US Classification:
604 8
Abstract:
The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF) by removing target compounds from CSF. The systems provide for a multilumen flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents.
Cerebrospinal Fluid Purification System
US Patent:
8435204, May 7, 2013
Filed:
Oct 9, 2007
Appl. No.:
12/444581
Inventors:
Shivanand Lad - Palo Alto CA, US
William C. Mobley - Stanford CA, US
Karoly Nikolich - Emerald Hill CA, US
Thomas Saul - El Granada CA, US
William C. Mobley - Stanford CA, US
Karoly Nikolich - Emerald Hill CA, US
Thomas Saul - El Granada CA, US
Assignee:
Neurofluidics, Inc. - San Mateo CA
International Classification:
A61M 1/00
US Classification:
604 9, 604 8
Abstract:
The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF) by removing target compounds from CSF. A multilumen flow path allows exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents.
Method Of Screening For Neuroprotective Agents
US Patent:
6265147, Jul 24, 2001
Filed:
Dec 1, 1999
Appl. No.:
9/452531
Inventors:
William C. Mobley - Palo Alto CA
Ronald J. Weigel - Woodside CA
Chengbiao Wu - San Jose CA
Har Hiu Dawn Lam - Stanford CA
Ronald J. Weigel - Woodside CA
Chengbiao Wu - San Jose CA
Har Hiu Dawn Lam - Stanford CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12Q 100
US Classification:
435 4
Abstract:
Neurological dysfunction is prevented or treated by the administration of ligands that activate the GPR30 receptor. Ligands include, but are not limited to, estrogens and structurally related molecules. In a preferred embodiment, the GPR30 ligand is an orally available drug that can cross into the brain from blood. Of particular interest are ligands that do not activate other estrogen receptors, and therefore do not have the classical estrogenic effects attributable to these receptors.
Method For Enhancing Learning And Memory Impaired By Neurodegenerative Disorders And Compounds And Compositions For Effecting The Same
US Patent:
2013009, Apr 18, 2013
Filed:
Apr 22, 2011
Appl. No.:
13/641987
Inventors:
Mehrdad Shamloo - Palo Alto CA, US
Mehrdad Faizi - Palo Alto CA, US
William Mobley - Palo Alto CA, US
Mehrdad Faizi - Palo Alto CA, US
William Mobley - Palo Alto CA, US
Assignee:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY - Palo Alto CA
International Classification:
A61K 31/5375, A61K 31/137, A61K 31/138
US Classification:
5142375, 514653, 514654, 800 9
Abstract:
A method for enhancing learning or memory of both in a mammal having impaired learning or emory of both from a neuro-degenerative disorder, which entails the step of administering at least one compound or a salt thereof which is a β-adrenergic receptor agonist, partial agonist or receptor ligand in an amount effective to improve the learning or memory or both of said mammal.